Consolidated Statements of Changes in Stockholders' Equity - USD ($) shares in Millions, $ in Millions	Total	Common Stock And Surplus	Retained Earnings	Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at May. 31, 2020		129.9
Beginning balance at May. 31, 2020	$ 2,331.2	$ 2,205.3	$ 143.5	$ (17.6)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	260.8		260.8
Other comprehensive income (loss)	18.3			18.3
Dividends declared	(88.1)		(88.1)
Stock option exercises (in shares)		0.5
Stock option exercises	27.1	$ 27.1
Stock-based compensation	32.2	$ 32.2
Repurchases of common stock (in shares)		(0.1)
Repurchases of common stock	(7.2)	$ (1.5)	(5.7)
Issuance of stock under Employee Stock Purchase Plan and other plans (in shares)		0.4
Issuance of stock under Employee Stock Purchase Plan and other plans	7.1	$ 7.1
Other	(5.9)	$ 1.6	(7.5)
Ending balance (in shares) at Feb. 28, 2021		130.7
Ending balance at Feb. 28, 2021	2,575.5	$ 2,271.8	303.0	0.7
Beginning balance (in shares) at Nov. 29, 2020		130.3
Beginning balance at Nov. 29, 2020	2,455.1	$ 2,239.0	223.2	(7.1)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	128.7		128.7
Other comprehensive income (loss)	7.8			7.8
Dividends declared	(48.6)		(48.6)
Stock option exercises (in shares)		0.4
Stock option exercises	21.5	$ 21.5
Stock-based compensation	9.2	9.2
Repurchases of common stock	(0.4)	0.0	(0.4)
Issuance of stock under Employee Stock Purchase Plan and other plans	2.3	2.3
Other	(0.1)	$ (0.2)	0.1
Ending balance (in shares) at Feb. 28, 2021		130.7
Ending balance at Feb. 28, 2021	2,575.5	$ 2,271.8	303.0	0.7
Beginning balance (in shares) at May. 30, 2021		130.8
Beginning balance at May. 30, 2021	2,813.1	$ 2,286.6	522.3	4.2
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	671.1		671.1
Other comprehensive income (loss)	(2.2)			(2.2)
Dividends declared	(427.9)		(427.9)
Stock option exercises (in shares)		0.5
Stock option exercises	28.7	$ 28.7
Stock-based compensation	28.0	$ 28.0
Repurchases of common stock (in shares)		(5.8)
Repurchases of common stock	(834.1)	$ (102.6)	(731.5)
Issuance of stock under Employee Stock Purchase Plan and other plans (in shares)		0.2
Issuance of stock under Employee Stock Purchase Plan and other plans	7.7	$ 7.7
Other	1.4	$ 1.4
Ending balance (in shares) at Feb. 27, 2022		125.7
Ending balance at Feb. 27, 2022	2,285.8	$ 2,249.8	34.0	2.0
Beginning balance (in shares) at Nov. 28, 2021		128.3
Beginning balance at Nov. 28, 2021	2,543.0	$ 2,280.6	261.8	0.6
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	247.0		247.0
Other comprehensive income (loss)	1.4			1.4
Dividends declared	(140.7)		(140.7)
Stock option exercises (in shares)		0.1
Stock option exercises	8.1	$ 8.1
Stock-based compensation	6.1	$ 6.1
Repurchases of common stock (in shares)		(2.7)
Repurchases of common stock	(381.8)	$ (47.7)	(334.1)
Issuance of stock under Employee Stock Purchase Plan and other plans	2.6	2.6
Other	0.1	$ 0.1
Ending balance (in shares) at Feb. 27, 2022		125.7
Ending balance at Feb. 27, 2022	$ 2,285.8	$ 2,249.8	$ 34.0	$ 2.0